...BioLabs launch neuro-focused incubator in CambridgeA U.S. subsidiary of Eisai Co. Ltd. (Tokyo:4523) partnered with BioLabs Inc....

...In 1993, Richard Roberts of New England Biolabs Inc....

...Phase I trial of LBL-007 in China in 3Q19. The company’s fully owned subsidiary Leads Biolabs Inc....

...Macrogen Inc. (KOSDAQ:038290) Seoul, South Korea Mission Bio Inc. South San Francisco, Calif. New England Biolabs Inc....

...include testing the combination of FACT inhibition and chemotherapy in additional models of SCLC. Cleveland BioLabs Inc....

...5 days before surgery with or without a second injection 3 days before surgery. Cleveland BioLabs Inc....

...cancer patients. The study is supported by a development contract with the Russian government. Cleveland BioLabs Inc....

...Cleveland BioLabs Inc. (NASDAQ:CBLI), Buffalo, N.Y. Business: Cancer, Other, Hematology Date announced: 2015-11-04 Type: Follow-on Underwriter: Ladenburg...

...to dose-dependent increases in circulating absolute neutrophil counts that lasted for about 20 hours. Cleveland BioLabs Inc....

...indirectly inhibit NF-κB in Phase I testing to treat non-small cell lung cancer (NSCLC). Cleveland BioLabs Inc....